...
首页> 外文期刊>Vlaams Diergeneeskundig Tijdschrift >Primary glaucoma in the dog: a review of known therapies and the research into future possibilities Part II: surgical therapy
【24h】

Primary glaucoma in the dog: a review of known therapies and the research into future possibilities Part II: surgical therapy

机译:狗的主要青光眼:对未来可能性的已知疗法和研究综述第二部分:手术治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Surgical treatment of glaucoma is directed toward altering aqueous humor production, drainage, or a combination of both. Increased intraocular pressure is a constant risk factor; addressing this factor represents the only treatable and measurable component in terms of successful glaucoma treatment. The optimal candidate for surgery is able to see, is in an early disease stage and has a normal optic nerve head without additional conditions. Dogs with a persistent high eye pressure, despite maximum levels of medical treatment, also qualify. Although the spectrum of medical and surgical therapies keeps growing, there is still no successful cure, and many affected dogs become blind. Regularly, eyes are enucleated because of painfully high, uncontrollable intraocular pressure. Because newly developed glaucoma medications are emerging at a very slow rate and may often not be effective in dogs, research toward improving surgical options may be the most rewarding approach in the near future.
机译:青光眼的手术治疗旨在改变幽默生产,排水或两者的组合。 口服压力增加是恒定的危险因素; 解决此因素代表成功的青光眼处理方面的唯一可治疗和可测量的组成部分。 手术的最佳候选者能够看到,是在早期疾病阶段,并且在没有额外条件的情况下具有常视神经头部。 尽管最高的医疗水平,但狗具有持续高的眼压,也有资格。 虽然医疗和手术治疗的谱不断增长,但仍然没有成功治愈,许多受影响的狗变得盲目。 经常,由于痛苦,无法控制的眼内压力,眼睛都是肌肉。 由于新开发的青光眼药物以非常慢的速度出现,并且可能在狗的情况下可能没有有效,因此改善手术选择的研究可能是在不久的将来最有价值的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号